ClinicalTrials.gg

Drug

Casein phosphopeptide-amorphous calcium phosphate nanocomplex clinical trials

studies test it
12
open now
1
in phase 3
1
first study started
2006

Keep track of what changes. Save the casein phosphopeptide-amorphous calcium phosphate nanocomplex studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

CPP-ACP
5
Tooth Mousse
2

Written with another drug

Sodium Fluoride with CPP-ACP
2

Studies by the year they started

12 studies that test it; most in 2019 (2)

Studies that test casein phosphopeptide-amorphous calcium phosphate nanocomplex, by start year
YearStudies
20061
20101
20111
20121
20131
20151
20161
20192
20201
20252

By phase

A phase 1/2 study counts in both.

Phase 2
4
Phase 3
1
Phase 4
3
No phase
4

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 0 · Other 12

University of Jazan (1) · Rania Salah (1) · Nourhan M.Aly (1) · University of California, San Francisco (1) · University of New England (1) · Merve Erkmen Almaz (1) · Fujian Medical University (1) · Thammasat University (1)

Often tested with

Tested in the same studies.

Sodium Fluoride (3) · Silver diamine fluoride (1) · NovaMin (1) · Tenocyclidine (1) · cow's milk (1)

Studies

Open first, then newest update. How each study uses casein phosphopeptide-amorphous calcium phosphate nanocomplex is read from its arms, and is right about nine times in ten.

Testing it · 12

As the comparator · 2 — what is tested is compared with casein phosphopeptide-amorphous calcium phosphate nanocomplex